Pharmacogenomics - A Personalized Approach to Medicine
This visiongain report provides you with the most comprehensive guide to
personalized medicines, numerous multicolored graphs and uniquely compiled
tables containing industry facts and figures - can you afford to be without it?.
Several companies are leading the pharmacogenomics revolution, which promises
to:
- Optimize the efficacy of therapeutic compounds
- Minimize adverse drug reactions and associated long-term costs
- Enhance the cost effectiveness of clinical trials
- Facilitate drug discovery, development, and approval
Despite the infancy of personalized medicines, genotype-specific medications
is no longer a fiction of the future, but a reality of the present.
A prime example of the potential benefits of applying genomic knowledge to
clinical therapy is the selective use of Herceptin drug in breast cancer
patients with genotypes that confer positive response to pharmacological
therapy.
This report will answer key questions such as:
- Which companies are leading the personalized medicine revolution?
- What R&D areas are set to show considerable growth?
- What are the benefits of investing in pharmacogenomics?
- Will a research focus on personalized medicine lead to dramatic changes in
clinical therapy?
- How will a pharmacogenomic approach improve the effectiveness of clinical
therapy, minimise adverse reactions and incurred costs from drug failures in
developmental phases?
- What are the knock-on effects of the Human Genome Project on current
research?
Contains:
This report presents an extensive and detailed guide to the development of
personalized medicines with its related research areas and technology that span
the biotechnology, diagnostics, bioinformatics, pharmacological and genomic
markets.
With 150+ pages, full-colour graphs, tables, case studies, cutting-edge
research studies, clinical trials, key industry figures and facts, company
profiles, R&D areas, this report provides an introduction to the principles
of pharmacogenomics and a detailed guide to personalized medicines that is set
to show considerable growth.
By drawing on detailed profiles of companies leading the revolution, this
report examines the wide range of areas that are ultimately linked to the
development of personalized medicines and how they effect your business today.
Why you must buy this report:
- Identify the level of competition and key players in the
personalizedmedicines revolution
- Insight into the potential benefits of pharmacogenomic research
- Forecast of emerging R&D areas
- How to enhance clinical trials and maximise product development potential